Genetically engineered magnetic nanocages for cancer magneto-catalytic theranostics

Genetically engineered magnetic nanocages for cancer magneto-catalytic theranostics

The clinical application of magnetic hyperthermia therapy (MHT) is limited by the poor magnetic-to-thermal conversion efficiency of MHT agents. Here, the authors develop encapsulin-produced magnetic iron oxide nanocomposites (eMIONs) with excellent magnetic-heat capability and catalysis-triggered tu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yang Zhang, Xiaoyong Wang, Chengchao Chu, Zijian Zhou, Biaoqi Chen, Xin Pang, Gan Lin, Huirong Lin, Yuxin Guo, En Ren, Peng Lv, Yesi Shi, Qingbing Zheng, Xiaohui Yan, Xiaoyuan Chen, Gang Liu
Format: article
Langue:EN
Publié: Nature Portfolio 2020
Sujets:
Science
Q
Accès en ligne:https://doaj.org/article/07fbdc0abb2d4e2db953b9c7d5286507
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Description
Résumé:The clinical application of magnetic hyperthermia therapy (MHT) is limited by the poor magnetic-to-thermal conversion efficiency of MHT agents. Here, the authors develop encapsulin-produced magnetic iron oxide nanocomposites (eMIONs) with excellent magnetic-heat capability and catalysis-triggered tumor suppression ability to overcome the critical issues of MHT.

Documents similaires